TE_38791
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | L1HS_5end |
|---|---|
| TE superfamily | L1 |
| TE class | LINE |
| Gene | - |
| Class | Intergenic |
| Coding | Non-coding |
| Tumor-specific score | 179.63 |
| Counts of samples | TCGA_tumor:1274; TCGA_normal:4; GTEx:3 |
| TSS | chrX(+):130573309 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_38791.11 | - | Intergenic | Non-coding | Non-coding | chrX(+):130573310,130573702,130575011,130575059,130601413,130601886,130602094,130602114 |
| teRNA_38791.12 | - | Intergenic | Non-coding | Non-coding | chrX(+):130573310,130573702,130574546,130574645,130575011,130575059,130601413,130601433 |
| teRNA_38791.13 | - | Intergenic | Non-coding | Non-coding | chrX(+):130573310,130573702,130574546,130574641,130575011,130575059,130601413,130601433 |
| teRNA_38791.14 | - | Intergenic | Non-coding | Non-coding | chrX(+):130573310,130573702,130574546,130574645,130575011,130575059,130596748,130596768 |
| teRNA_38791.15 | - | Intergenic | Non-coding | Non-coding | chrX(+):130573310,130573702,130574546,130574641,130575011,130575059,130596748,130596768 |
| teRNA_38791.16 | - | Intergenic | Non-coding | Non-coding | chrX(+):130573310,130573702,130574546,130575059,130601413,130601433 |
| teRNA_38791.17 | - | Intergenic | Non-coding | Non-coding | chrX(+):130573310,130573702,130574546,130574641,130575011,130575059,130601413,130601700,130602094,130602114 |
| teRNA_38791.18 | - | Intergenic | Non-coding | Non-coding | chrX(+):130573310,130573702,130574546,130575059,130596748,130596768 |
| teRNA_38791.19 | - | Intergenic | Non-coding | Non-coding | chrX(+):130573310,130573702,130574546,130575059,130601413,130601886,130602094,130602114 |
| teRNA_38791.20 | - | Intergenic | Non-coding | Non-coding | chrX(+):130573310,130573702,130574546,130574645,130575011,130575059,130596748,130596819,130601413,130601433 |
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
